Data Sciences International
Private Company
Total funding raised: $14.5M
Overview
Data Sciences International (DSI) is a mission-critical infrastructure provider for the preclinical life sciences sector, specializing in high-fidelity physiologic monitoring systems for laboratory animals. Founded in 1980, the company has established an authoritative track record with its technology cited in over 16,000 publications and used to monitor more than 750,000 research subjects. Its strategy focuses on integrated hardware and software platforms that enable stress-free, continuous data collection, thereby enhancing research quality and efficiency. DSI operates as a key, revenue-generating subsidiary of Harvard Bioscience, serving a global customer base.
Technology Platform
Integrated platform for preclinical physiologic monitoring, featuring implantable and external telemetry, respiratory/inhalation systems (Buxco), and specialized software suites (FinePointe, NeuroScore, Data Insights) for continuous, high-fidelity data acquisition and analysis.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
DSI holds a dominant position in integrated preclinical telemetry, competing with specialists like emka TECHNOLOGIES and ADInstruments. Its key advantages are unparalleled scientific validation (16,000+ citations), a full-spectrum platform, and a large global installed base, creating high switching costs for customers.